Clinical trial

DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Support Dopaminergic Desensitization in PD

NCT05579379

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2022-10-01

PhaseN/A

Study timeline

Study start (estimated)2022-10-01Date precision: month

Registry last updated2022-10-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

Sponsors & collaborators

University Hospital Tuebingenlead sponsor

STADAPHARM GmbHcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05579379 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.